InMode is a global leader in energy-based medical aesthetics, redefining how clinics drive both clinical outcomes and commercial success. Built on clinically proven radiofrequency (RF) and intense pulsed light (IPL) technology, InMode’s platforms enable minimally invasive and non-invasive treatments across face, body, women’s health, and now ocular wellness.
Envision by InMode taps into one of the fastest-growing, under-served markets: dry eye. Envision is used to treat dry eye disease caused by meibomian gland dysfunction, as well as to improve skin quality, reduce inflammation, and stimulate collagen production. By targeting the underlying causes rather than just symptoms, Envision offers a minimally invasive, in-office solution that can enhance eye health, comfort, and overall appearance with little to no downtime. For clinics looking to diversify, medicalise their offering, and drive consistent income, Envision is a gamechanger.